Clinical Data shows that Q-1802 has significant anti-tumor activity.

Duoning Biotechnology Group ("Duoning") announced a strategic partnership agreement with Branca Bunús Ltd. ("Branca Bunús"). Under this agreement, the two companies will collaborate on the development ...

Strengthened financial position resulting from recently announced MARGENZA® transaction and previously announced receipt of milestone payment ...

NJ Bio and Charles River announce a Strategic Alliance to seamlessly advance ADC Development and Manufacturing Services for ...